Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Kino Indonesia Tbk (KINO.JK)
Tangerang, ID
PT Kino Indonesia Tbk manufactures and distributes a diverse range of consumer products both domestically within Indonesia and across international markets. Its extensive portfolio includes personal care items, various beverages, food products, pharmaceutical goods, and pet food. The company's personal care offerings encompass haircare solutions under brands like Ellips, Sasha, and Samantha; oral hygiene products such as Sasha and Click; skincare items including Ovale and Ristra; baby care essentials via Sleek Baby; cosmetics from Abstract; fragrances under Eskulin; and feminine hygiene products like Resik V and Absolute. It also caters to children's personal care needs with B&B Kids, Eskulin Kids, and Master Kids, and provides men's grooming products through the Master brand. Additionally, its personal care segment features air fresheners (Evergreen), hygiene products like hand sanitizers (Sleek, Instance Hand Sanitizer), and pet foods marketed under the MAXLife brand. In the beverage sector, PT Kino Indonesia offers remedy drinks (Cap Kaki Tiga, Larutan Sejuk Segar), health-focused beverages (Cap Panda), energy drinks (Panther), and a selection of canned fruits, coconut water, and juices from the Malee brand. Its food division includes confectionery, such as candies under Kino Candy, Oplozz, Frenta Candy, and Chew Chew Ball, alongside snacks like Kino Naster and Snack It, and powdered drink mixes from the Segar Sari brand. Furthermore, the company produces pharmaceutical items, including herbal cough medicines, balms, headache relief, and ringworm treatments (Cap Kaki Tiga, Q-Life), as well as general herbal products under the Dua Putri Dewi brand. Established in 1999, the company, previously known as PT Kinocare Era Kosmetindo, maintains its headquarters in Tangerang, Indonesia, and operates as a subsidiary of PT Kino Investindo.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +3.60% | +2.68% | -3.77% | -8.37% | -16.97% | +4.07% | -22.56% | -47.96% | -80.09% | -70.13% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+1.2% Q1'26: +11.4% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%+42.8% ★ Q1'26: +63.9% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%+1.0% Q1'26: +11.2% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%+4.8% Q1'26: +7.1% (vs Q1'25)
-
ROIC Conglomerates: +4.7%+5.3% ★ Q1'26: +11.4% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×3.76× Q1'26: 3.62× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.60T
est: 3.62T (-0.4%)
|
3.49T
est: 3.50T (-0.1%)
|
3.16T
est: 3.25T (-2.7%)
|
3.61T
est: 3.48T (+3.9%)
|
4.68T
est: 4.73T (-1.0%)
|
4.02T
est: 4.16T (-3.2%)
|
3.98T
est: 3.96T (+0.3%)
|
3.63T
est: 3.87T (-6.2%)
|
4.14T
est: 3.88T (+6.7%)
|
4.37T
est: 4.26T (+2.5%)
|
4.42T
est: 4.78T (-7.5%)
|
| EBITDA |
425.68B
est: 185.89B (+129.0%)
|
350.93B
est: 179.54B (+95.5%)
|
257.61B
est: 166.88B (+54.4%)
|
304.12B
est: 178.49B (+70.4%)
|
799.57B
est: 242.70B (+229.4%)
|
406.54B
est: 213.57B (+90.3%)
|
464.89B
est: 203.57B (+128.4%)
|
-544.64B
est: 198.80B (-374.0%)
|
344.23B
est: 199.04B (+72.9%)
|
461.29B
est: 767.99B (-39.9%)
|
415.31B
est: 860.97B (-51.8%)
|
| EBIT |
425.68B
est: 48.03B (+786.2%)
|
239.08B
est: 46.39B (+415.3%)
|
213.97B
est: 43.12B (+396.2%)
|
258.32B
est: 46.12B (+460.1%)
|
719.35B
est: 62.72B (+1,047.0%)
|
281.88B
est: 55.19B (+410.8%)
|
291.84B
est: 52.60B (+454.8%)
|
-746.36B
est: 51.37B (-1,552.9%)
|
282.27B
est: 51.43B (+448.8%)
|
254.74B
est: 573.34B (-55.6%)
|
211.30B
est: 642.76B (-67.1%)
|
| Net Income |
263.02B
est: 227.03B (+15.9%)
|
180.60B
est: 172.85B (+4.5%)
|
110.42B
est: 111.46B (-0.9%)
|
150.15B
est: 132.28B (+13.5%)
|
520.44B
est: 215.48B (+141.5%)
|
113.70B
est: 207.34B (-45.2%)
|
105.04B
est: 108.10B (-2.8%)
|
-950.29B
est: -207.37B (-358.3%)
|
70.46B
est: 60.76B (+16.0%)
|
86.60B
est: 90.91B (-4.7%)
|
123.70B
est: 118.35B (+4.5%)
|
| SGA |
1.04T
est: 1.01T (+3.0%)
|
1.17T
est: 975.37B (+19.5%)
|
777.24B
est: 906.60B (-14.3%)
|
971.33B
est: 969.71B (+0.2%)
|
1.19T
est: 1.32T (-9.4%)
|
960.13B
est: 1.16T (-17.3%)
|
1.11T
est: 1.11T (+0.6%)
|
1.26T
est: 1.08T (+16.6%)
|
1.06T
est: 1.08T (-2.3%)
|
1.20T
est: 1.30T (-8.2%)
|
1.65T
est: 1.46T (+13.0%)
|
| EPS |
234.00
est: 164.66 (+42.1%)
|
126.00
est: 125.36 (+0.5%)
|
77.00
est: 80.83 (-4.7%)
|
105.10
est: 95.93 (+9.6%)
|
364.31
est: 156.28 (+133.1%)
|
79.59
est: 150.38 (-47.1%)
|
73.53
est: 78.40 (-6.2%)
|
-682.23
est: -150.40 (-353.6%)
|
50.58
est: 44.07 (+14.8%)
|
62.81
est: 65.93 (-4.7%)
|
89.71
est: 85.83 (+4.5%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 240.82 | 0.33% |
| 2 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 3.2K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Budi Susanto | Sales & Marketing Director and Director | — | male |
| Clara A. Linanda | Corporate Secretary | — | — |
| Harry Sanusi | President Director | — | male |
| Melly Setiawati | Head of Payroll Department | — | — |
| Sidharta Prawira Oetama | President Director | — | male |
| Sumianty Lie | Head of Internal Audit Unit | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KINO.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
